KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $516.2 million.

  • Edwards Lifesciences' Free Cash Flow rose 7212.4% to $516.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $804.2 million, marking a year-over-year increase of 5600.39%. This contributed to the annual value of $289.9 million for FY2024, which is 5490.04% down from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Free Cash Flow is $516.2 million, which was up 7212.4% from $240.9 million recorded in Q2 2025.
  • Edwards Lifesciences' Free Cash Flow's 5-year high stood at $516.2 million during Q3 2025, with a 5-year trough of -$177.3 million in Q4 2024.
  • In the last 5 years, Edwards Lifesciences' Free Cash Flow had a median value of $250.0 million in 2022 and averaged $226.0 million.
  • Within the past 5 years, the most significant YoY rise in Edwards Lifesciences' Free Cash Flow was 210069.93% (2024), while the steepest drop was 46708.07% (2024).
  • Edwards Lifesciences' Free Cash Flow (Quarter) stood at $283.8 million in 2021, then fell by 24.63% to $213.9 million in 2022, then plummeted by 77.42% to $48.3 million in 2023, then crashed by 467.08% to -$177.3 million in 2024, then skyrocketed by 391.14% to $516.2 million in 2025.
  • Its last three reported values are $516.2 million in Q3 2025, $240.9 million for Q2 2025, and $224.4 million during Q1 2025.